StudyImprovementRR · 95% CIOutcomeTreatmentControlRelative Risk
Early treatment−36%1.36 · 0.31–5.924/1043/10636% higher risk
Tau² = 0.00, I² = 0.0%, p = 0.7
All studies−36%1.36 · 0.31–5.924/1043/10636% higher risk
Tau² = 0.00, I² = 0.0%, p = 0.700.511.52+
Rotate screen for more detailsIncrease width for more details
← BMS mAbs
reduces riskBMS mAbs
increases risk →